Ticker: RXRX

Company: RECURSION PHARMACEUTICALS, INC.

Person: Blake Borgeson, director

Transaction date: April 7, 2026

Reporting date: April 8, 2026

Average share price: 3.1

Sold 30000.0 shares for 93000.0